These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12589591)

  • 1. [Acarbose can slow down beginning of type 2 diabetes].
    Lanzendörfer C
    Dtsch Med Wochenschr; 2003 Jan; 128(4):162; discussion 162. PubMed ID: 12589591
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention by life style intervention and medication. To run away from type 2 diabetes].
    Wepner U
    MMW Fortschr Med; 2004 Apr; 146(14):16. PubMed ID: 15344745
    [No Abstract]   [Full Text] [Related]  

  • 3. [Robert Koch Award for acarbose. Antidiabetic drug prevents myocardial infarct].
    MMW Fortschr Med; 2003 Feb; 145(6):59. PubMed ID: 12619367
    [No Abstract]   [Full Text] [Related]  

  • 4. [Late diagnosis. Only after infarct is diabetes detected].
    MMW Fortschr Med; 2004 Jan; 146(5):51. PubMed ID: 15035427
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary prevention of type 2 diabetes: how do we do it?
    Abdul-Ghani MA; Sabah M; Minuchin O; Vardi P; Raz I; Wainstein J
    Isr Med Assoc J; 2004 May; 6(5):305-7. PubMed ID: 15151376
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacologic prevention or delay of type 2 diabetes mellitus.
    Anderson DC
    Ann Pharmacother; 2005 Jan; 39(1):102-9. PubMed ID: 15562143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acarbose--an effective drug for the prevention of type 2 diabetes and cardiovascular diseases?].
    Laakso M
    Duodecim; 2003; 119(20):1921-3. PubMed ID: 14639996
    [No Abstract]   [Full Text] [Related]  

  • 8. [Already in altered glucose tolerance an antidiabetic drug. Significantly fewer heart attacks].
    MMW Fortschr Med; 2003 Jan; 145(3-4):57. PubMed ID: 12619238
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cardioprotection by acarbose--contra].
    Kaiser T; Sawicki PT
    Dtsch Med Wochenschr; 2004 May; 129(20):1156. PubMed ID: 15143460
    [No Abstract]   [Full Text] [Related]  

  • 10. [Postprandial blood glucose as the driving force in pathogenesis of type 2 diabetes].
    Liebl A
    Med Klin (Munich); 2003 Oct; 98 Suppl 1():7-11. PubMed ID: 14694835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acarbose for type 2 diabetes prevention.
    Mühlhauser I
    Lancet; 2002 Nov; 360(9344):1517; author reply 1517. PubMed ID: 12433559
    [No Abstract]   [Full Text] [Related]  

  • 12. Acarbose for type 2 diabetes prevention.
    Scheen AJ
    Lancet; 2002 Nov; 360(9344):1516; author reply 1517. PubMed ID: 12433557
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacologic treatment options for prediabetes.
    Hsueh WA; Handelsman Y
    Nat Clin Pract Endocrinol Metab; 2008 Jul; 4(7):380-1. PubMed ID: 18523427
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cardioprotection by acarbose--pro].
    Breuer HW
    Dtsch Med Wochenschr; 2004 May; 129(20):1155. PubMed ID: 15143459
    [No Abstract]   [Full Text] [Related]  

  • 15. [Spectrum of apolipoproteins of blood serum in patients with non- insulin-dependent diabetes mellitus on acarbose treatment].
    Rosliakova LV; Roĭtman AP; Rakov SS; Ametov AS; Dolgov VV
    Klin Med (Mosk); 1999; 77(10):15-7. PubMed ID: 10635646
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular benefits of acarbose in impaired glucose tolerance and type 2 diabetes.
    Zeymer U
    Int J Cardiol; 2006 Feb; 107(1):11-20. PubMed ID: 16337493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dangerous blood glucose peaks. Vascular damage even before diabetes].
    MMW Fortschr Med; 2003 Sep; 145(35-36):53. PubMed ID: 14584214
    [No Abstract]   [Full Text] [Related]  

  • 18. [Does targeted therapy of type 2 diabetes prevent cardiovascular incidents?].
    Leschke M
    Med Klin (Munich); 2003 Oct; 98 Suppl 1():12-6. PubMed ID: 14694836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined treatment with exercise training and acarbose improves metabolic control and cardiovascular risk factor profile in subjects with mild type 2 diabetes.
    Wagner H; Degerblad M; Thorell A; Nygren J; Ståhle A; Kuhl J; Brismar TB; Ohrvik J; Efendic S; Båvenholm PN
    Diabetes Care; 2006 Jul; 29(7):1471-7. PubMed ID: 16801564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-prandial hyperglycaemia and prevention of cardiovascular disease.
    Davies MJ
    Diabet Med; 2005 Jan; 22 Suppl 1():6-9. PubMed ID: 15610148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.